Licensing

SKY

IS

THE

LIMIT

Partnership Opportunities

LSC will consider licensing and development for custom design co-engineering of Hydroxysomes® with any API / bioactive including hydrophilic and hydrophobic actives. LSC will be responsible for the development and manufacturing of the new innovative active raw material.

This includes:

  • Stabilization Technology
  • Sustained Release
  • Dermal Delivery
  • Encapsulation Technology

Key Features

  • Damage-free/non-invasive
  • No need for penetration enhancers
  • Delivery through intact skin
  • Increased skin penetration
  • Highly stable, safe and non-toxic
  • Improved stability of bioactives
  • Sustained release
  • Increased efficiency/bio-availability
  • Non-irritating
  • Ease of formulation
  • UVA/UVB SPF Booster

Joint Ventures & Development of Topical Drugs With Pharmaceutical Partners

Pharmaceutical Applications:

  • Extend proprietary Protection & Provide Brand Evergreening
  • Development of Drug Product Intermediate (DPI)
  • Licensing and supply of DPI
jaJapanese